HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marc Cohen Selected Research

otamixaban

3/2021Prevalence, clinical determinants and prognostic implications of coronary procedural complications of percutaneous coronary intervention in non-ST-segment elevation myocardial infarction: Insights from the contemporary multinational TAO trial.
1/2021Sex Differences in Ischemic and Bleeding Outcomes in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From the TAO Trial.
10/2020Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy.
10/2020Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy.
1/2018Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial.
11/2017Timing of Angiography and Outcomes in High-Risk Patients With Non-ST-Segment-Elevation Myocardial Infarction Managed Invasively: Insights From the TAO Trial (Treatment of Acute Coronary Syndrome With Otamixaban).
9/2013Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial.
5/2007Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention: the SEPIA-PCI trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marc Cohen Research Topics

Disease

72Hemorrhage
01/2021 - 09/2002
69Myocardial Infarction
01/2021 - 05/2002
56Acute Coronary Syndrome
03/2021 - 01/2002
32ST Elevation Myocardial Infarction
03/2021 - 01/2002
25Stroke (Strokes)
01/2021 - 11/2005
20Thrombosis (Thrombus)
10/2020 - 10/2002
15Atrial Fibrillation
01/2021 - 06/2006
11Unstable Angina
02/2020 - 01/2002
10Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2002
9Neoplasms (Cancer)
07/2022 - 03/2006
9Non-ST Elevated Myocardial Infarction
02/2020 - 01/2002
8Ischemia
04/2019 - 01/2002
8Coronary Disease (Coronary Heart Disease)
09/2016 - 05/2004
7Pain (Aches)
12/2022 - 03/2003
7Heart Failure
10/2020 - 03/2008
7Coronary Artery Disease (Coronary Atherosclerosis)
02/2020 - 05/2004
7Infarction (Infarctions)
01/2019 - 01/2002
6Hypertension (High Blood Pressure)
01/2021 - 05/2011
5Cardiogenic Shock
01/2019 - 10/2002
4COVID-19
12/2021 - 01/2020
4Diabetes Mellitus
01/2021 - 05/2003
4Peripheral Arterial Disease
01/2020 - 04/2016
3Thromboembolism
12/2021 - 06/2006
3Venous Thromboembolism
12/2021 - 05/2011
3Infertility (Sterility)
09/2021 - 07/2014
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2019 - 04/2010
3Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2018 - 01/2012
3Ischemic Stroke
09/2016 - 05/2004
3Common Cold
11/2014 - 07/2009
2Inflammation (Inflammations)
12/2022 - 03/2006
2Sepsis (Septicemia)
12/2021 - 12/2021
2Pituitary Neoplasms (Pituitary Adenoma)
10/2021 - 10/2018
2Anemia
01/2021 - 07/2002
2Hypertrophy
01/2021 - 01/2021
2Squamous Cell Carcinoma of Head and Neck
01/2021 - 11/2018
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
12/2020 - 01/2016
2Heart Arrest (Cardiac Arrest)
11/2020 - 10/2015
2Infections
01/2020 - 03/2006

Drug/Important Bio-Agent (IBA)

44Heparin (Liquaemin)FDA LinkGeneric
12/2021 - 01/2002
42Enoxaparin (Lovenox)FDA LinkGeneric
01/2017 - 01/2002
22Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2021 - 09/2002
19TicagrelorIBA
01/2021 - 04/2014
19AnticoagulantsIBA
11/2019 - 01/2002
14Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
12/2021 - 01/2002
13RivaroxabanIBA
11/2019 - 10/2010
12Vitamin KFDA Link
11/2019 - 06/2006
102'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
05/2020 - 07/2013
9omega-Chloroacetophenone (Mace)IBA
01/2021 - 10/2008
9Glycoproteins (Glycoprotein)IBA
01/2018 - 10/2002
8Eptifibatide (Integrilin)FDA Link
03/2021 - 01/2002
8otamixabanIBA
03/2021 - 05/2007
7Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2018 - 01/2002
7Tirofiban (Aggrastat)FDA Link
06/2005 - 01/2002
6Clopidogrel (Plavix)FDA Link
02/2020 - 10/2010
6Warfarin (Coumadin)FDA LinkGeneric
11/2019 - 05/2004
6AntithrombinsIBA
07/2011 - 07/2004
5Biomarkers (Surrogate Marker)IBA
12/2022 - 01/2020
5Troleandomycin (TAO)FDA Link
03/2021 - 09/2013
4Oxygen (Dioxygen)IBA
12/2021 - 11/2014
4Factor Xa (Coagulation Factor Xa)IBA
01/2021 - 05/2007
4TroponinIBA
11/2020 - 08/2017
4Hemoglobins (Hemoglobin)IBA
10/2020 - 01/2003
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020 - 12/2006
4Antiviral Agents (Antivirals)IBA
11/2014 - 07/2009
3HomocysteineIBA
09/2021 - 12/2011
3CreatinineIBA
10/2020 - 03/2008
3ThrombinFDA Link
12/2018 - 12/2009
3Purinergic P2Y Receptor AntagonistsIBA
05/2015 - 12/2009
3Factor Xa InhibitorsIBA
10/2014 - 10/2008
3Fibrinolytic Agents (Antithrombotic Agents)IBA
08/2012 - 01/2004
3Platelet Membrane Glycoprotein IIbIBA
10/2003 - 01/2002
2Folic Acid (Vitamin M)FDA LinkGeneric
10/2022 - 01/2020
2AcidsIBA
12/2021 - 10/2020
2fibrin fragment D (D-dimer)IBA
12/2021 - 12/2021
2Alkylating AgentsIBA
10/2021 - 10/2018
2NivolumabIBA
10/2021 - 10/2018
2Temozolomide (Temodar)FDA LinkGeneric
10/2021 - 10/2018
2IpilimumabIBA
10/2021 - 10/2018
2saxagliptinFDA Link
01/2021 - 01/2021
2CholesterolIBA
11/2020 - 01/2009
2Adenosine Diphosphate (ADP)IBA
02/2020 - 12/2009
2Prasugrel HydrochlorideFDA Link
02/2020 - 10/2010
2trans-crotonin (CTN)IBA
02/2020 - 08/2017

Therapy/Procedure

62Therapeutics
07/2022 - 01/2002
49Percutaneous Coronary Intervention
03/2021 - 01/2002
12Coronary Artery Bypass (Coronary Artery Bypass Surgery)
02/2020 - 10/2003
10Stents
10/2020 - 07/2013
7Patient Readmission
02/2020 - 09/2002
7Transcatheter Aortic Valve Replacement
10/2019 - 01/2016
7Counterpulsation (External Counterpulsation)
01/2019 - 10/2002
4Length of Stay
01/2022 - 12/2016
4Radiotherapy
01/2019 - 04/2010
4Secondary Prevention
12/2018 - 05/2004
4Drug Therapy (Chemotherapy)
10/2018 - 05/2009
3Blood Transfusion (Blood Transfusions)
06/2013 - 01/2003
2Immunotherapy
10/2021 - 10/2018
2Extracorporeal Membrane Oxygenation
11/2020 - 01/2016
2Catheters
11/2020 - 06/2002
2Thrombectomy
11/2020 - 07/2018
2Contraindications
01/2020 - 05/2010